Trial Profile
A study whether miglitol and sitagliptin improves glycemic control and reduces the expressions of CVD risk factors in patients with in type 2 diabetic Japanese patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Miglitol (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Dec 2015 New trial record